Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Figure E. Secondary Antimicrobial Drug Used to Treat Gonorrhea among GISP Participants, 2013

 
This web page is archived for historical purposes and is no longer being updated.
 

CLINICPercentage
Doxy/TetAzi/EryNone/Other
ALBUQUERQUE.98.61.4
ATLANTA1.795.03.3
BALTIMORE8.291.8.
BIRMINGHAM42.556.21.4
CHICAGO3.096.01.0
CLEVELAND3.696.4.
COLUMBUS.97.03.0
DALLAS.100.0.
DENVER30.369.20.5
GREENSBORO.100.0.
HONOLULU1.498.6.
INDIANAPOLIS.99.01.0
KANSAS CITY1.095.73.3
LAS VEGAS.100.0.
LOS ANGELES1.092.86.2
MIAMI11.888.2.
MINNEAPOLIS1.091.87.2
NEW ORLEANS1.498.6.
NEW YORK CITY6.487.26.4
OKLAHOMA CITY14.981.63.4
ORANGE COUNTY2.496.80.8
PHILADELPHIA1.096.03.0
PHOENIX.98.31.7
PONTIAC.96.33.7
PORTLAND.98.41.6
RICHMOND.100.0.
SAN DIEGO0.689.210.2
SAN FRANCISCO0.798.50.7
SEATTLE2.187.410.5
TRIPLER.90.99.1
Top